Figure 2. Consent for reinterpretation.
(a) Responses to the question, “Should consent be required prior to reinterpretation?” Pairwise comparisons between the patients/parents compared to clinical genetic providers or laboratory genetic providers AND between the non-genetic providers compared to clinical genetic providers or laboratory genetic providers all had a p-value of <.0001 (chi-square analysis). (b) Response from those who responded yes (n=692, 39% of the total sample) to the multiple-choice question of “At what point should consent for reinterpretation be obtained?” The option of “other” was available but was removed from the figure.